发明授权
- 专利标题： Imidazoquinoxaline compounds as immunomodulators
- 专利标题（中）： 咪唑喹喔啉化合物作为免疫调节剂
-
申请号： US12294233申请日： 2007-03-23
-
公开(公告)号： US08173657B2公开(公告)日： 2012-05-08
- 发明人: James Sutton , Feng Xu , Nicholas Valiante , Jiong Lan
- 申请人： James Sutton , Feng Xu , Nicholas Valiante , Jiong Lan
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Helen Lee; Robert Gorman; Otis Littlefield
- 国际申请： PCT/US2007/064858 WO 20070323
- 国际公布： WO2007/109813 WO 20070927
- 主分类号： A61K31/50
- IPC分类号： A61K31/50 ; A61K39/02 ; A61K39/12 ; A61K39/00 ; C07D471/00 ; C07D487/00
摘要：
The invention provides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent(s).
公开/授权文献
- US20090311288A1 IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS 公开/授权日：2009-12-17
信息查询
